H.L. Ormond & Company’s Regeneron Pharmaceuticals REGN Stock Holding History

H.L. Ormond & Company’s Portfolio REGN Stock Details REGN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$230K	Sell
2022 Q2	$215K	Sell
2022 Q1	$362K	Sell
2021 Q4	$323K	Buy